Christopher Dinsmore, Chief Scientific Officer at Kronos Bio, Inc. (KRON), sold 22,598 shares at $12.36 ($279K) on 2021-12-13, disclosed to the SEC on 2021-12-15.
Open-market sale of $279k KRON by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.36 | 11,212 | $139K | 49.6% |
| 2 | $12.36 | 11,212 | $139K | 49.6% |
| 3 | $12.82 | 174 | $2K | 0.8% |
| Total | $12.36 avg | 22,598 | $279K | 100% |
| Filing → |
| KRON | SELL | 2023-07-07 | $12K | — | Filing → |
| KRON | SELL | 2023-02-24 | $11K | — | Filing → |
| KRON | SELL | 2022-12-14 | $17K | — | Filing → |